Glenn Bubley

Beth Israel Deaconess Medical Center

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 153 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplemental Figure 3 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Atish D. Choudhury,Lucia Kwak,Alexander Cheung,Kathryn M. Allaire,Jaqueline Marquez,David D. Yang,Abhishek Tripathi,Jacqueline M. Kilar,Meredith Flynn,Brianna Maynard,Rebecca Reichel,Amanda F. Pace,Brandon K. Chen,Eliezer M. Van Allen,Kerry Kilbridge,Xiao X. Wei,Bradley A. McGregor,Mark M. Pomerantz,Rupal S. Bhatt,Christopher J. Sweeney,Glenn J. Bubley,Heather A. Jacene,Mary-Ellen Taplin,Franklin W. Huang,Lauren C. Harshman,Lawrence Fong

crossref（2024）

Cited0Views0Bibtex

Testosterone Recovery and Associated Impact on Patient-Reported Health-Related Quality of Life (hrqol) after Treatment with 6 Months of GnRH Agonist with or Without Abiraterone Acetate Plus Prednisone (AAP) and Apalutamide (apa) in the FORMULA-509 Trial

S. Moningi,P. L. Nguyen,D. Rathkopf,A. Zurita-Saavedra,D. E. Spratt,R. T. Dess,S. Liauw,R. Szmulewitz,D. J. Einstein,G. Bubley,J. B. Yu,Y. An, A. G. Wong,F. Y. Feng,R. R. Mckay,B. S. Rose, K. Y. Shin,M. E. A. Taplin,M. A. Kollmeier,K. E. Hoffman

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2024）

Cited0Views0Bibtex

Supplemental Table 3 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

Cited0Views0Bibtex

Supplemental Figure 8 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

Cited0Views0Bibtex

Supplemental Table 6 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Atish D. Choudhury,Lucia Kwak,Alexander Cheung,Kathryn M. Allaire,Jaqueline Marquez,David D. Yang,Abhishek Tripathi,Jacqueline M. Kilar,Meredith Flynn,Brianna Maynard,Rebecca Reichel,Amanda F. Pace,Brandon K. Chen,Eliezer M. Van Allen,Kerry Kilbridge,Xiao X. Wei,Bradley A. McGregor,Mark M. Pomerantz,Rupal S. Bhatt,Christopher J. Sweeney,Glenn J. Bubley,Heather A. Jacene, Mary-Ellen Taplin,Franklin W. Huang,Lauren C. Harshman,Lawrence Fong

crossref（2024）

Cited0Views0Bibtex

Supplemental Figure 7 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

Cited0Views0Bibtex

Supplemental Figure 5 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

Cited0Views0Bibtex

Long-Term Patient-Reported Health -Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide after Radical Prostatectomy

K. E. Hoffman,P. L. Nguyen,D. Rathkopf,A. Zurita-Saavedra,D. E. Spratt,R. T. Dess,S. Liauw,R. Szmulewitz,D. J. Einstein,G. Bubley,J. B. Yu,Y. An,A. C. Wong,F. Y. Feng,R. R. Mckay,B. S. Rose, K. Y. Lee,A. Kibel,M. E. A. Taplin,M. A. Kollmeier

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2024）

Cited1Views0Bibtex

Supplemental Figure 4 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

Cited0Views0Bibtex

Supplemental Figure 6 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

Cited0Views0Bibtex

Author Statistics

#Papers: 153

#Citation: 7061

H-Index: 31

G-Index: 82

Sociability: 7

Diversity: 3

Activity: 75

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn